Therapeutic Apheresis Market, By Technology (Centrifugation and Membrane filtration), By Procedure Type, By End User, By Application, By Component, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4520
|
Published Date
November 2025
|
Pages
386
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
The Therapeutic Apheresis Market size was valued at US$ 2,879.23 Million in 2024, expanding at a CAGR of 4.1% from 2025 to 2032.
Therapeutic apheresis is a medical procedure in which a patient’s blood is drawn, specific components are selectively removed, and the remaining blood is returned to the body. The therapeutic apheresis market is primarily driven by the increasing global prevalence of autoimmune and neurological disorders, fueling demand for procedures such as plasma exchange and leukapheresis. Additionally, the expanding use of apheresis in advanced cell therapies, including CAR-T and stem cell treatments, is creating significant growth opportunities for device manufacturers and service providers. Market expansion is, however, limited by the high costs of equipment and procedures, which restrict widespread adoption in low- and middle-income countries. Governments are actively supporting the development and accessibility of apheresis therapies; for instance, the U.S. Centers for Medicare & Medicaid Services (CMS) reimbursed over USD 500 million for therapeutic apheresis procedures in 2023, while the European Union’s Horizon E
Therapeutic Apheresis Market- Market Dynamics
Rising Prevalence of Chronic Conditions Expected to Drive Market Growth
The increasing prevalence of chronic conditions is expected to drive growth in the apheresis consumables and equipment market. Chronic diseases—long-lasting health conditions that often persist for a lifetime—frequently require ongoing management and treatment. Apheresis consumables and equipment play a critical role in managing these conditions by enabling the selective removal or collection of specific blood components in disorders such as autoimmune diseases, familial hypercholesterolemia, sickle cell disease, and for stem cell harvesting. According to the U.S. National Library of Medicine, by 2035 nearly 36% of American adults aged 50 and older will have at least one chronic condition, with projections rising to approximately 48% by 2050. This rising burden of chronic diseases is fueling demand for apheresis technologies, driving market expansion.
Therapeutic Apheresis Market- Segmentation Analysis:
The worldwide market is segmented on the basis of Technology, Procedure Type, End User, Application, Component, and Region.
The component segment of the global therapeutic apheresis market is divided into five key categories: Plasmapheresis, LDL Apheresis, Leukapheresis, Photopheresis, and Others. Among these, plasmapheresis holds a significant market share, driven by the rising prevalence of autoimmune and neurological disorders influenced by genetic factors and changing lifestyle patterns. According to the Multiple Sclerosis International Federation, the number of people living with multiple sclerosis increased from 2.8 million in 2020 to 2.9 million in 2023, highlighting the growing population in need of therapeutic interventions. Plasmapheresis is crucial for managing these conditions as it removes inflammatory agents, autoantibodies, and other harmful substances from the bloodstream, reducing the severity and duration of disease relapses. Consequently, healthcare providers are increasingly incorporating plasmapheresis into treatment strategies, supporting continued segment growth.
In terms of end-users, blood banks represent a prominent and highly utilized segment in the therapeutic apheresis market due to their vital role in collecting, processing, and supplying blood components for both therapeutic and emergency purposes. These facilities routinely perform apheresis procedures—including plasmapheresis, plateletpheresis, and leukapheresis—to ensure the availability of specialized blood components for patients with autoimmune, oncological, and hematological disorders. Blood banks benefit from established infrastructure, standardized operating procedures, and high donor throughput, enabling them to meet consistent demand for advanced apheresis systems and consumables. The segment’s importance is further reinforced by initiatives to boost donor engagement and expand collection capacity. For example, in 2023, Singapore opened a new blood collection center at the One Punggol integrated community hub to address rising demand and encourage greater donor participation, particularly among younger populations. These developments underscore the growing emphasis on robust blood-collection networks, making blood banks a critical and expanding segment within the therapeutic apheresis market.
Therapeutic Apheresis Market- Geographical Insights
North America holds a significant share of the global therapeutic apheresis market, driven by a high prevalence of chronic and hematological disorders. For example, the Global Cancer Observatory estimated approximately 71,700 new cases of leukemia in North America in 2022. Additionally, the Centers for Disease Control and Prevention (CDC) reported in 2023 that around 100,000 Americans are affected by sickle cell disease (SCD). This substantial patient population underscores the growing need for advanced therapeutic solutions, fueling market demand in the region. Rising per capita healthcare consumption, coupled with increasing health expenditures and economic growth, is encouraging the adoption of innovative apheresis therapies, further contributing to market expansion in North America.
United States Therapeutic Apheresis Market- Country Insights
The United States represents the largest market in the region. The country’s growing geriatric population is a key driver of market growth, as an aging population is associated with an increased incidence of cancer and other chronic diseases. This trend is expected to significantly contribute to regional market expansion. Additionally, the rising prevalence of blood-related disorders—such as kidney disease, metabolic disorders, cancer, and neurological conditions—along with the presence of well-established healthcare infrastructure and high patient awareness, are major factors fueling the growth of the market in North America.
According to the Leukemia & Lymphoma Society (LLS), a person in the United States is diagnosed with blood cancer every three minutes. In 2020, approximately 178,520 individuals were diagnosed with leukemia, lymphoma, or myeloma in the country. These three types of blood cancer accounted for 9.8% of the 1,898,160 new cancer cases reported in the United States in 2021. Consequently, the high prevalence of these target diseases is a significant driver of market growth.
Therapeutic Apheresis Market- Competitive Landscape:
The therapeutic apheresis market is moderately consolidated, with innovation, technology integration, and procedural efficiency serving as key differentiators. Companies in this sector primarily compete by developing advanced apheresis systems that offer greater automation, enhanced safety profiles, and reduced procedure times. Consumables, service contracts, and training programs are also critical elements of competitive strategy, as healthcare providers increasingly prefer vendors that offer comprehensive operational support. Market participants are expanding the clinical applications of apheresis, including autoimmune, neurological, and cell-therapy indications, to enhance adoption and clinical relevance. Competitive advantages are further strengthened by regulatory approvals, evidence-based clinical data, and integration with digital monitoring platforms.
Recent Developments:
- August 2023: TERUMO BCT, INC received FDA approval for an innovative platelet device capable of producing platelets from blood in a single centrifugation cycle, improving both the speed and reliability of blood component preparation.
- August 2023: Fresenius Kabi AG and Lupagen Inc. signed a supply and development agreement focused on advancing technologies to enhance the delivery of cell and gene therapies directly to patients in clinical settings.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL THERAPEUTIC APHERESIS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Baxter Healthcare Corporation
- Kawasumi Laboratories Inc.
- Therakos Incorporation
- Mallinckrodt Plc
- Asahi Kasei Medical Co.
- Haemonetics Corporation
- Miltenyi Biotec
- Terumo BCT
- Asahi Kasei Medical
- B. Braun Melsungen AG
- Nikkiso Co. Ltd.
- Cerus Corporation
- Terumo BCT Inc.
- Fresenius Kabi USA
- Medica S.p.A.
- Others
GLOBAL THERAPEUTIC APHERESIS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- Centrifugation
- Membrane filtration
GLOBAL THERAPEUTIC APHERESIS MARKET, BY PROCEDURE TYPE- MARKET ANALYSIS, 2019 - 2032
- Therapeutic plasma exchange (TPE)
- Cellular depletions
- Red blood cell exchange (RBCX)
- Other procedures
GLOBAL THERAPEUTIC APHERESIS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Specialty clinics
- Blood banks
- Ambulatory surgical centers
GLOBAL THERAPEUTIC APHERESIS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Neurology
- Oncology
- Sickle cell disease
- Autoimmune disease
- Graft-versus-host disease (GVHD)
- Nephrology
- Familial hypercholesterolemia
- Transplant of solid organs
GLOBAL THERAPEUTIC APHERESIS MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032
- Plasmapheresis
- LDL Apheresis
- Leukapheresis
- Photopheresis
- Others
GLOBAL THERAPEUTIC APHERESIS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Therapeutic Apheresis Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Therapeutic Apheresis Market Snippet by Technology
2.1.2. Therapeutic Apheresis Market Snippet by Procedure Type
2.1.3. Therapeutic Apheresis Market Snippet by End User
2.1.4. Therapeutic Apheresis Market Snippet by Application
2.1.5. Therapeutic Apheresis Market Snippet by Component
2.1.6. Therapeutic Apheresis Market Snippet by Country
2.1.7. Therapeutic Apheresis Market Snippet by Region
2.2. Competitive Insights
3. Therapeutic Apheresis Key Market Trends
3.1. Therapeutic Apheresis Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Therapeutic Apheresis Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Therapeutic Apheresis Market Opportunities
3.4. Therapeutic Apheresis Market Future Trends
4. Therapeutic Apheresis Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Therapeutic Apheresis Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Therapeutic Apheresis Market Landscape
6.1. Therapeutic Apheresis Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Therapeutic Apheresis Market – By Technology
7.1. Overview
7.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
7.1.2. Centrifugation
7.1.3. Membrane filtration
8. Therapeutic Apheresis Market – By Procedure Type
8.1. Overview
8.1.1. Segment Share Analysis, By Procedure Type, 2024 & 2032 (%)
8.1.2. Therapeutic plasma exchange (TPE)
8.1.3. Cellular depletions
8.1.4. Red blood cell exchange (RBCX)
8.1.5. Other procedures
9. Therapeutic Apheresis Market – By End User
9.1. Overview
9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
9.1.2. Hospitals
9.1.3. Specialty clinics
9.1.4. Blood banks
9.1.5. Ambulatory surgical centers
10. Therapeutic Apheresis Market – By Application
10.1. Overview
10.1.1. Segment Share Analysis, By Procedure Type, 2024 & 2032 (%)
10.1.2. Neurology
10.1.3. Oncology
10.1.4. Sickle cell disease
10.1.5. Autoimmune disease
10.1.6. Graft-versus-host disease (GVHD)
10.1.7. Nephrology
10.1.8. Familial hypercholesterolemia
10.1.9. Transplant of solid organs
11. Therapeutic Apheresis Market – By Component
11.1. Overview
11.1.1. Segment Share Analysis, By Component, 2024 & 2032 (%)
11.1.2. Plasmapheresis
11.1.3. LDL Apheresis
11.1.4. Leukapheresis
11.1.5. Photopheresis
11.1.6. Others
12. Therapeutic Apheresis Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. Therapeutic Apheresis Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Therapeutic Apheresis Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.3.11.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.11.7. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Therapeutic Apheresis Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.8. APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.4.9.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.9.7. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.4.10.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.10.7. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Therapeutic Apheresis Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.8. LATAM Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Therapeutic Apheresis Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Therapeutic Apheresis Industry
13.1. Competitive Benchmarking
13.1.1. Competitive Dashboard
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. Baxter Healthcare Corporation
13.2.2. Kawasumi Laboratories Inc.
13.2.3. Therakos Incorporation
13.2.4. Mallinckrodt Plc
13.2.5. Asahi Kasei Medical Co.
13.2.6. Haemonetics Corporation
13.2.7. Miltenyi Biotec
13.2.8. Terumo BCT
13.2.9. Asahi Kasei Medical
13.2.10. B. Braun Melsungen AG
13.2.11. Nikkiso Co. Ltd.
13.2.12. Cerus Corporation
13.2.13. Terumo BCT Inc.
13.2.14. Fresenius Kabi USA
13.2.15. Medica S.p.A.
13.2.16. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL THERAPEUTIC APHERESIS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Baxter Healthcare Corporation
- Kawasumi Laboratories Inc.
- Therakos Incorporation
- Mallinckrodt Plc
- Asahi Kasei Medical Co.
- Haemonetics Corporation
- Miltenyi Biotec
- Terumo BCT
- Asahi Kasei Medical
- B. Braun Melsungen AG
- Nikkiso Co. Ltd.
- Cerus Corporation
- Terumo BCT Inc.
- Fresenius Kabi USA
- Medica S.p.A.
- Others
GLOBAL THERAPEUTIC APHERESIS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- Centrifugation
- Membrane filtration
GLOBAL THERAPEUTIC APHERESIS MARKET, BY PROCEDURE TYPE- MARKET ANALYSIS, 2019 - 2032
- Therapeutic plasma exchange (TPE)
- Cellular depletions
- Red blood cell exchange (RBCX)
- Other procedures
GLOBAL THERAPEUTIC APHERESIS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Specialty clinics
- Blood banks
- Ambulatory surgical centers
GLOBAL THERAPEUTIC APHERESIS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Neurology
- Oncology
- Sickle cell disease
- Autoimmune disease
- Graft-versus-host disease (GVHD)
- Nephrology
- Familial hypercholesterolemia
- Transplant of solid organs
GLOBAL THERAPEUTIC APHERESIS MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032
- Plasmapheresis
- LDL Apheresis
- Leukapheresis
- Photopheresis
- Others
GLOBAL THERAPEUTIC APHERESIS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
